Recent events

November 4th, 2024 Nomination of Landes-Innovationspreis Niedersachsen for Start-up NanoDrug Delivery GmbH
October 25th, 2024 Congratulation to Andreas Reiß for passing PhD exam
September 19th, 2024 Wegbereiter-Award by Börsenclub Hannover for Start-up NanoDrug Delivery GmbH
September 16th - 18th, 2024 Inorganic Chemistry Conference of the GDCh, TU Munich (4 posters, 1 oral)
  Start-up "NanoDrug Delivery GmbH" launched
July 19th, 2024 Congratulation to Felix Jung for passing PhD exam
May 23rd, 2024 "Wissenschaftspreis" (sponsored by Sartorius AG) & audience award for start-up "CaBiDi Drug Delivery UG" (represented by CEO Dr. D. Rudolph)
                      Start-up Competition LIFT-OFF, Göttingen University
June 6th, 2024 Conversion / capital increase of start-up "CaBiDi Drug Delivery UG" to "NanoDrug Delivery GmbH"
June 13th - 16th, 2024 Hirschegg-Seminar on Solid-State Chemistry, Hirschegg, Austria
August 2nd, 2024 Group excursion to "Lusoria Rhenana" (Roman river boat), Neupotz, Rhineland Palatinate
August 3rd, 2024 Alumni meeting of the Feldmann group
August 7th - 9th, 2024 Hosting the PhD workshop "Nanotage"
December 15th, 2024 Congratulation to Maxime Bonnin for passing PhD exam
 Myrto Ischyropoulou / Max-Planck-Institut für Multidisziplinäre Naturwissenschaften
Nanoparticles for optimized cancer therapy

Pancreatic cancer is one of the deadliest types of cancers in humans. It is the fourth leading cause of cancer-related deaths in the western world. The early stages of the disease often progress without symptoms, so diagnosis is usually very late. Another problem: Advanced tumors – and their metastases – can no longer be completely removed. Chemotherapies, in turn, attack not only the tumor cells but also healthy cells throughout the body. Innovative nanoparticles could be a new approach to treat cancer more precisely. The approach was developed by a research team from the Max Planck Institute (MPI) for Multidisciplinary Sciences, the University Medical Center Göttingen (UMG), and the Karlsruhe Institute of Technology (KIT). The therapy is now to be optimized for clinical application as quickly as possible.

learn more